Liang Song
Amministratore Delegato presso Insight Lifetech Co., Ltd.
Profilo
Liang Song is the founder of Insight Lifetech Co., Ltd., a company founded in 2015.
He currently holds the titles of Chairman, CEO & General Manager at Insight Lifetech Co., Ltd.
Prior to founding Insight Lifetech Co., Ltd., Dr. Song worked as the Director-Laboratory for Biomedical Optics at The Shenzhen Institutes of Advanced Technology from 2012 to 2016.
Dr. Song obtained a doctorate degree from Washington University in St. Louis in 2010.
He also holds an undergraduate degree from Wuhan University, which he received in 2003, and a graduate degree from The Chinese University of Hong Kong, which he obtained in 2006.
Posizioni attive di Liang Song
| Società | Posizione | Inizio |
|---|---|---|
Insight Lifetech Co., Ltd.
 Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Amministratore Delegato | 11/12/2015 |
Precedenti posizioni note di Liang Song
| Società | Posizione | Fine |
|---|---|---|
| The Shenzhen Institutes of Advanced Technology | Corporate Officer/Principal | 01/03/2016 |
Formazione di Liang Song
| Washington University in St. Louis | Doctorate Degree |
| Wuhan University | Undergraduate Degree |
| The Chinese University of Hong Kong | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |
- Borsa valori
- Insiders
- Liang Song
